Arthritis News and Research

Latest Arthritis News and Research

'Think twice' campaign effective in reducing opioid prescribing in primary care

A campaign that urged GPs to 'think-twice' before putting a patient on opioid medicines is effective in reducing opioid prescribing in primary care, according to the findings of a major study.

5 Oct 2021

Is gout a risk factor for COVID-19?

A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.

4 Oct 2021

Experimental vaccine shows significant promise in preventing rheumatoid arthritis

Researchers at The University of Toledo have developed an experimental vaccine that shows significant promise in preventing rheumatoid arthritis, a painful autoimmune disease that cannot currently be cured.

4 Oct 2021

Online searches for arthritis symptoms increase among UK residents

Online searches for symptoms of arthritis and osteoarthritis increase with residents throughout the UK.

4 Oct 2021

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Real-world data looking at biologic treatment and vaccine hesitancy in psoriasis patients is being presented today at EADV’s 30th Congress.

1 Oct 2021

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

A new study aimed to determine the course of SARS-CoV-2 infection in children suffering from rheumatic disease and were receiving bDMARD treatment.

29 Sep 2021

Researchers discover working mechanism of potential drug targets for COVID-19

A team of international researchers, including McGill Professor Stéphane Laporte, have discovered the working mechanism of potential drug targets for various diseases such as cancer, rheumatoid arthritis, and even COVID-19.

28 Sep 2021

Biosimilar drugs are cheaper than biologics. Are they similar enough to switch?

It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes.

23 Sep 2021

UTSW researchers discover how vitamin A enters immune cells in the intestines

Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.

16 Sep 2021

Pew announces support for the 2021 class of Innovation Fund investigators

The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2021 class of Innovation Fund investigators.

15 Sep 2021

Gut microbiome profile could help predict patient's rheumatoid arthritis prognosis

A significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in their gut, according to new research from Mayo Clinic's Center for Individualized Medicine.

14 Sep 2021

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).

14 Sep 2021

Newly developed antibody may be used to treat muscular dystrophy

Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, findings that were published in Science Translational Medicine.

13 Sep 2021

Researchers create a QIBA profile for cartilage compositional imaging

New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology.

7 Sep 2021

Practical solutions in shoulder arthroplasty for patients with glenoid bone loss

Today, at the American Academy of Orthopaedic Surgeons (AAOS) 2021 annual meeting, Hospital for Special Surgery (HSS) sports medicine surgeon David M. Dines, MD, participated in an instructional case lecture on practical solutions in shoulder arthroplasty for patients with substantial shoulder socket bone loss known as glenoid bone deficiency.

4 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

A simple blood test could determine which drug and dosage is more likely to be effective against rheumatoid arthritis, potentially saving sufferers serious side effects and Australian taxpayers millions of dollars.

2 Sep 2021

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

A new study by researchers at Winship Cancer Institute of Emory University finds that cancer-associated mutations originate in blood progenitor cells, leading to distinct changes in both cancer and non-cancer immune cells in Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma and its precursor IgM monoclonal gammopathy of undetermined significance (MGUS).

2 Sep 2021

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

1 Sep 2021

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

1 Sep 2021

Arthritis News and Research

Latest Arthritis News and Research

'Think twice' campaign effective in reducing opioid prescribing in primary care

Is gout a risk factor for COVID-19?

Experimental vaccine shows significant promise in preventing rheumatoid arthritis

Online searches for arthritis symptoms increase among UK residents

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Researchers discover working mechanism of potential drug targets for COVID-19

Biosimilar drugs are cheaper than biologics. Are they similar enough to switch?

UTSW researchers discover how vitamin A enters immune cells in the intestines

Pew announces support for the 2021 class of Innovation Fund investigators

Gut microbiome profile could help predict patient's rheumatoid arthritis prognosis

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Newly developed antibody may be used to treat muscular dystrophy

Researchers create a QIBA profile for cartilage compositional imaging

Practical solutions in shoulder arthroplasty for patients with glenoid bone loss

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Arthritis News and Research

Latest Arthritis News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in